JAMP Pharma Corporation is recalling its digoxin tablets because some bottles may contain an incorrect dose, Health Canada announced in an advisory. The drug-maker said its 0.0625 and 0.125 mg digoxin ...

What to do: Return your JAMP Digoxin 0.0625 mg tablets to your pharmacy for replacement as soon as possible. Until you can return them, continue to take your JAMP Digoxin, but do not take any tablets ...

Digoxin recalled over mislabeling Two lots of Digoxin were mislabeled, leading to a recall. Digoxin is used for the treatment of mild to moderate heart failure in children and adults. The Food and ...

A potentially life threatening label mistake caused Marlex Pharmaceuticals to recall two lots of heart failure medication Digoxin. Here’s what you need to know. Digoxin 0.125 mg tablets, lot No. E3810 ...

WASHINGTON, March 31 (UPI) -- The U.S. Food and Drug Administration announced the recall of Caraco-brand digoxin tablets with an expiration date of September 2011 due to a safety hazard. The FDA said ...

Caraco Pharmaceutical has issued a nationwide voluntary recall to the consumer level of all Caraco brand digoxin 0.125mg and 0.25mg tablets distributed prior to March 31, 2009, which are not expired ...

AS Medication Solutions, a drug repackage company, announced today that all Caraco brand digoxin 0.25mg tablets, distributed prior to March 31, 2009, which are not expired and are within the ...

The Food and Drug Administration announced the recall of one lot of Digoxin Tablets USP, 0.125 mg, and one lot of Digoxin Tablets USP, 0.25 mg. Bottles of Digoxin Tablets, USP 0.125 mg are incorrectly ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A monitor is seen ...